Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes "STANCE"


Phase 3 Results N/A

Summary of Purpose

The investigators hypothesize that pre-operative statin use is neuroprotective at maximal doses. The goals are to determine the safety, feasibility, and efficacy of maximizing statin doses for two weeks (12-18 days) prior to CEA using change in performance on a battery neuropsychometric tests as outcome measure. Study will recruit patients based on their preexisting statin regimen. The investigators...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 June 2017.

1 Jun 2017 27 Jul 2016 1 Oct 2021 1 Apr 2022 1 Jun 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment